IL123404A - Antisecretory factor peptides regulating pathological permeability changes - Google Patents

Antisecretory factor peptides regulating pathological permeability changes

Info

Publication number
IL123404A
IL123404A IL12340496A IL12340496A IL123404A IL 123404 A IL123404 A IL 123404A IL 12340496 A IL12340496 A IL 12340496A IL 12340496 A IL12340496 A IL 12340496A IL 123404 A IL123404 A IL 123404A
Authority
IL
Israel
Prior art keywords
homologues
fragments
antisecretory factor
permeability changes
protein
Prior art date
Application number
IL12340496A
Other languages
English (en)
Other versions
IL123404A0 (en
Original Assignee
Rural Patent Svenska Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rural Patent Svenska Ab filed Critical Rural Patent Svenska Ab
Priority to IL15290996A priority Critical patent/IL152909A0/xx
Publication of IL123404A0 publication Critical patent/IL123404A0/xx
Publication of IL123404A publication Critical patent/IL123404A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
IL12340496A 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes IL123404A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL15290996A IL152909A0 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9502936A SE508609C2 (sv) 1995-08-24 1995-08-24 Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
PCT/SE1996/001049 WO1997008202A1 (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes

Publications (2)

Publication Number Publication Date
IL123404A0 IL123404A0 (en) 1998-09-24
IL123404A true IL123404A (en) 2005-07-25

Family

ID=20399269

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12340496A IL123404A (en) 1995-08-24 1996-08-23 Antisecretory factor peptides regulating pathological permeability changes

Country Status (29)

Country Link
US (2) US6344440B1 (xx)
EP (1) EP0851876B1 (xx)
JP (2) JP4040679B2 (xx)
KR (1) KR100552947B1 (xx)
CN (1) CN1171902C (xx)
AT (1) ATE270305T1 (xx)
AU (1) AU702589B2 (xx)
BG (1) BG63209B1 (xx)
BR (1) BR9610308A (xx)
CA (1) CA2230111C (xx)
CZ (1) CZ295444B6 (xx)
DE (2) DE69632828T2 (xx)
DK (1) DK0851876T3 (xx)
EA (1) EA001201B1 (xx)
EE (1) EE04501B1 (xx)
ES (1) ES2118683T3 (xx)
HK (1) HK1018468A1 (xx)
HU (1) HU224971B1 (xx)
IL (1) IL123404A (xx)
NO (1) NO320560B1 (xx)
NZ (2) NZ316647A (xx)
PL (1) PL188530B1 (xx)
PT (1) PT851876E (xx)
RO (1) RO120197B1 (xx)
SE (1) SE508609C2 (xx)
SI (1) SI0851876T1 (xx)
SK (1) SK23698A3 (xx)
TR (1) TR199800304T1 (xx)
WO (1) WO1997008202A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
SE9604251L (sv) * 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
CA2340721A1 (en) * 1999-06-21 2001-01-25 George Tuszynski Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
PL2037950T3 (pl) 2006-04-27 2014-09-30 Lantmaennen As Faktor Ab Dodatkowe zastosowania medyczne białka antysekrecyjnego
DK2468292T3 (da) * 2006-04-27 2020-03-23 Lantmaennen Medical Ab Nyt peptid med antisekretorisk aktivitet
DK2363140T3 (en) * 2006-04-27 2017-03-06 Lantmännen As-Faktor Ab ANTI-SECRETORIC PROTEIN TO USE IN THE TREATMENT OF COMPARTMENT SYNDROME
US8901083B2 (en) 2008-11-25 2014-12-02 Temple University Administration of angiocidin for the treatment of leukemia
EP3769778A1 (en) 2009-02-11 2021-01-27 Lantmännen Medical AB Use of antisecretory factors (af) for optimizing cellular uptake
CA2992057C (en) 2015-07-10 2021-07-20 Lantmannen As-Faktor Ab Process for producing egg yolk with high content of af-16
JP6999638B2 (ja) * 2016-07-18 2022-01-18 ラントメネン・メディカル・アーベー 抗分泌性因子１７
CA3103164A1 (en) 2018-06-28 2020-01-02 Lantmannen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
EP3855934A2 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted dehulled oat
CA3173436A1 (en) 2020-03-26 2021-09-30 Leif Goransson A consumable product comprising malted cereals for promoting recovery at physical activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning

Also Published As

Publication number Publication date
HU224971B1 (en) 2006-04-28
DE851876T1 (de) 1998-11-12
AU6893296A (en) 1997-03-19
BR9610308A (pt) 1999-12-21
RO120197B1 (ro) 2005-10-28
PL325114A1 (en) 1998-07-06
JPH11511972A (ja) 1999-10-19
NZ316647A (en) 1999-10-28
DE69632828T2 (de) 2005-07-14
NO980743L (no) 1998-04-16
DK0851876T3 (da) 2004-10-25
US20020099016A1 (en) 2002-07-25
SE9502936D0 (sv) 1995-08-24
SK23698A3 (en) 1998-12-02
NO320560B1 (no) 2005-12-19
CN1171902C (zh) 2004-10-20
KR100552947B1 (ko) 2006-04-21
CN1208420A (zh) 1999-02-17
HUP9900137A2 (hu) 1999-04-28
NO980743D0 (no) 1998-02-23
EE9800055A (et) 1998-08-17
TR199800304T1 (xx) 1998-05-21
NZ337380A (en) 2001-02-23
CA2230111A1 (en) 1997-03-06
HUP9900137A3 (en) 1999-11-29
BG102280A (en) 1999-04-30
CZ295444B6 (cs) 2005-08-17
KR19990044110A (ko) 1999-06-25
PL188530B1 (pl) 2005-02-28
US6344440B1 (en) 2002-02-05
EP0851876A1 (en) 1998-07-08
DE69632828D1 (de) 2004-08-05
ATE270305T1 (de) 2004-07-15
EE04501B1 (et) 2005-06-15
SE508609C2 (sv) 1998-10-19
EA001201B1 (ru) 2000-12-25
BG63209B1 (bg) 2001-06-29
SI0851876T1 (en) 2004-10-31
EP0851876B1 (en) 2004-06-30
IL123404A0 (en) 1998-09-24
EA199800221A1 (ru) 1998-10-29
WO1997008202A1 (en) 1997-03-06
ES2118683T1 (es) 1998-10-01
AU702589B2 (en) 1999-02-25
HK1018468A1 (en) 1999-12-24
CA2230111C (en) 2012-10-30
ES2118683T3 (es) 2004-12-01
SE9502936L (sv) 1997-02-25
JP2008043331A (ja) 2008-02-28
CZ52098A3 (cs) 1998-09-16
PT851876E (pt) 2004-10-29
JP4040679B2 (ja) 2008-01-30

Similar Documents

Publication Publication Date Title
HK1018468A1 (en) Antisecretory factor peptides regulating pathological permeability changes.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ATE389666T1 (de) Hohe expressionsrate von proteinen
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
DE68916537D1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
EA200000216A1 (ru) Белки, связывающие интерлейкин-18, их получение и применение
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DK564989D0 (da) Bindingsproteiner
ATA168590A (de) Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
DE69028783D1 (de) Künstliche peptide, die die zellbindung steigern
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
ATE315646T1 (de) Leukocyten-aktivierender faktor
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
TW342413B (en) Novel toxins isolated from Bracon Hebetor
AU5990100A (en) ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
Terletskaya et al. BINDING OF PROTEIN SCP WITH MYELIN, ITS IDENTITY WITH PROTEIN P2. A SIMPLE METHOD OF PROTEIN P2 ISOLATION
MX24651A (es) Compuestos de adn recombinante, vectores de expresion de mutantes de glicosilacion de la proteina c humana, celulas huesped transformadas y metodo para la produccion recombinante de formas zimogenas de proteina c humana.
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
DE59509921D1 (de) Integrationsvektoren zur Herstellung von Genen, die rekombinante Antikörper codieren

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired